« Previous
Next »
Lung Cancer
Volume 67, Issue 3
, Pages 296-300
, March 2010
Tumor size matters differently in pulmonary adenocarcinoma and squamous cell carcinoma
References
- . Risk factors for occult nodal metastasis in clinical T1N0 lung cancer: a negative impact on survival. Eur J Cardiothorac Surg. 2008;33:466–469
- Tumor size is a determinant of stage distribution in T1 non-small cell lung cancer. Chest. 2005;128:2304–2308
- . The prognostic impact of tumor size in resected stage I non-small cell lung cancer: evidence for a two thresholds tumor diameters classification. Lung Cancer. 2006;54:185–191
- . International Early Lung Cancer Action Program Investigators. Computed tomographic screening for lung cancer: the relationship of disease stage to tumor size. Arch Intern Med. 2006;166:321–325
- Clinical predictors of metastatic disease to the brain from non-small cell lung carcinoma: primary tumor size, cell type, and lymph node metastases. Radiology. 2007;242:882–888
- . Impact of tumor size on survival in stage IA non-small cell lung cancer: a case for subdividing stage IA disease. Lung Cancer. 2003;42:51–57
- . Surgical results and prognostic factors in early non-small cell lung cancer. Ann Thorac Surg. 1997;63:324–326
- . Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery (GCCB-S). Eur Respir J. 1999;14:812–816
- The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol. 2007;2:694–705
- . Distribution according to histologic type and outcome by gender and age group in Taiwanese patients with lung carcinoma. Cancer. 2005;103:2566–2574
- . Recent developments in the epidemiology of lung cancer. Semin Surg Oncol. 1993;9:73–79
- . Time trends in the outcome of lung cancer management: a study of 9,090 cases diagnosed in the Mersey Region, 1974–86. Br J Cancer. 1990;61:590–596
- Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst. 2005;97:339–346
- Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity. J Clin Oncol. 2006;24:2245–2251
- . Stage of lung cancer in relation to its size: part 2. Evidence. Chest. 2005;127:1136–1139
- . Metastasis: the seed and soil theory gains identity. Cancer Metastasis Rev. 2007;26:705–715
- Multivariate analysis of factors predictive of brain metastases in localized non-small cell lung carcinoma. Lung Cancer. 2004;45:317–323
- . Adenocarcinoma of the lung: recent results from the Veterans Administration Lung Group. Am Rev Respir Dis. 1979;120:1025–1029
- . Intracranial recurrence of carcinoma after complete surgical resection of stage I, II, and III non-small-cell lung cancer. N Engl J Med. 1988;318:1300–1305
- Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med. 2004;350:2129–2139
- EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA. 2004;101:13306–13311
- . Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008;83:584–594
- . The changing epidemiology of lung cancer. Methods Mol Biol. 2009;472:397–411
- . Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst. 1999;21:1194–1210
- . Molecular genetics of lung cancer in people who have never smoked. Lancet Oncol. 2008;9:676–682
PII: S0169-5002(09)00255-4
doi: 10.1016/j.lungcan.2009.04.017
© 2009 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
Lung Cancer
Volume 67, Issue 3
, Pages 296-300
, March 2010
